Vertex Pharmaceuticals | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2024-12
Acadia Pharmaceuticals USD 16K 0 2024-12
Agios Pharmaceuticals USD 73K 0 2024-12
Alnylam Pharmaceuticals USD 1.29M 4K 2024-12
Amgen USD 33.53B 140M 2024-12
Arrowhead Research USD 218K 1000 2024-12
Biogen USD 100K 0 2024-12
BioMarin Pharmaceutical USD 191K 0 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
Gilead Sciences USD 1000K 0 2024-12
Incyte USD 193K 1000 2024-12
Insmed USD 1.79M 6K 2024-12
Ionis Pharmaceuticals USD 158K 0 2024-12
J&J USD 3.12B 0 2024-12
Merck USD 1.79B 0 2024-12
Moderna USD 38.6K 100 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 480M 0 2024-12
PTC Therapeutics USD 77K 1000 2024-12
Regeneron Pharmaceuticals USD 100K 2K 2024-09
Roche Holding CHF 107M 0 2024-06
Sarepta Therapeutics USD 10K 0 2024-12
Ultragenyx Pharmaceutical USD 92K 0 2024-12
United Therapeutics USD 800K 100K 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Vertex Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.